Skip to main content

MetLife Investment Management, LLC

Position in KROS — Keros Therapeutics, Inc.

CIK 1529735 Whippany, NJ

Position in KROS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$178,497
-$5,672 QoQ
Shares Held
16,682
0.0% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 132 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KROS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $430,307,229 across 249 Biotechnology names. KROS ranks #202 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KROS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $178,497 16,682
2026-03-31 $184,169 16,682
2025-12-31 $339,645 16,682
2025-09-30 $312,429 19,749
2025-06-30 $263,649 19,749
2025-03-31 $184,418 18,098
2024-12-31 $286,491 18,098
2024-09-30 $991,312 17,071
2024-06-30 $780,144 17,071
2024-03-31 $870,066 13,143
2023-12-31 $472,547 11,885
2023-09-30 $378,893 11,885
2023-06-30 $477,539 11,885
2023-03-31 $431,141 10,097
2022-12-31 $484,857 10,097
2022-09-30 $318,077 8,455
2022-06-30 $233,611 8,455
2022-03-31 $459,782 8,455
2021-12-31 $319,230 5,456
2021-09-30 $215,839 5,456
2021-06-30 $231,716 5,456
2021-03-31 $335,816 5,456
2020-12-31 $384,866 5,456
2020-09-30 $146,951 3,810
2020-06-30 $142,913 3,810